Finance JournalistFinance journalist at Grafa. Covers tech, crypto, and markets, making complex finance clear for all. Passionate about innovation and trends.
Greenwich LifeSciences (NASDAQ:GLSI) announced today that the European Medicines Agency (EMA) has completed its regulatory review and approved the use of its commercially manufactured GP2 immunotherapy lot for the ongoing Phase III FLAMINGO-01 clinical trial.
Ionis Pharmaceuticals (NASDAQ:IONS) and its development partner AstraZeneca (NYSE:AZN) announced today that their Phase 3 CARDIO-TTRansform clinical trial evaluating eplontersen did not meet its primary efficacy endpoint.
Nexo has launched its dual-mode crypto card in Argentina, allowing eligible users to spend cryptocurrency directly or borrow against their digital asset holdings without selling them as the company expands across Latin America.
Kraken has emerged as the leading MiCA-regulated crypto exchange with more than US$400 million in spot liquidity and over US$220 million in perpetual liquidity.
Cobre (ASX:CBE) has secured firm commitments to raise $90 million through a two-tranche share placement.
Viva Republica, operator of Toss, has reportedly partnered with Optimism and Sunnyside Labs to conduct a three-month proof of concept for a Korean won-based stablecoin payment system aimed at financial institutions.
European Union officials are reportedly preparing to revise the Markets in Crypto-Assets (MiCA) framework to expand oversight of non-EU stablecoin issuers following the introduction of the United States' GENIUS Act.
Zach Rynes, a community lead for Chainlink, criticised Ripple's five-year sponsorship with the University of Kansas, arguing that promoting XRP (CRYPTO:XRP) through college sports does not align with the company's institutional payments business.
Catalyst Metals (ASX:CYL) implements a new gold price protection regime at its flagship Plutonic Gold Belt operations.
The Bitcoin Standard Treasury Company (BSTR), backed by more than 30,000 Bitcoin (CRYPTO:BTC), and Cantor Equity Partners I have ended the original terms of their 2025 SPAC merger agreement and will negotiate a revised deal for a planned public listing.
